Vironova BioAnalytics
Biotechnology ResearchStockholm, Sweden11-50 Employees
Vironova BioAnalytics is a biotechnology firm founded in 2005 and based in Stockholm, Sweden. The company provides integrated electron microscopy analysis services, combining hardware and software capabilities to support the development of biopharmaceuticals from sample preparation through imaging to final analytics, with the aim of delivering actionable data that informs decision-making and patient safety. Serving the global life sciences community, Vironova emphasizes enabling faster and more cost-effective analysis within a GMP-certified TEM laboratory, positioning itself as a full-service provider across the value chain. Its client base spans researchers and developers in gene therapy, vaccines, and drug development, seeking to simplify transmission electron microscopy workflows and gain insights into subvisible structures that impact product quality and safety. In recent developments, the firm has been associated with strategic changes in ownership and ongoing collaboration efforts to advance analysis methods for gene therapy vectors and cargo.